Edgewise Therapeutics, Inc. (EWTX) stock analysis

In our weekly check, Edgewise Therapeutics, Inc. is graded D (A to F). Of 19 checks on debt, profit, cash flow and trend: 9 pass, warnings: 0, red flags: 10.

About Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as EWTX.

What our checks show for EWTX

Red flags

Strengths

Similar companies

COGT · TVTX · IONS · DNTH · ADPT · SRRK

Questions

What grade does Edgewise Therapeutics, Inc. (EWTX) have?

In our weekly check, Edgewise Therapeutics, Inc. is graded D (A to F). Of 19 checks on debt, profit, cash flow and trend: 9 pass, warnings: 0, red flags: 10. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of EWTX stock?

This week's biggest flags for Edgewise Therapeutics, Inc.: Profits not backed by cash, Weak EPS forecast, Margins expected to shrink. In total 10 of 19 checks show a warning or a red flag.

What does Edgewise Therapeutics, Inc. do?

Edgewise Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as EWTX.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis